ENSYSCE BIOSCIENCES INC (ENSC) Fundamental Analysis & Valuation

NASDAQ:ENSC • US2936025046

Current stock price

0.407 USD
-0.03 (-6.22%)
At close:
0.4054 USD
0 (-0.39%)
After Hours:

This ENSC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. ENSC Profitability Analysis

1.1 Basic Checks

  • In the past year ENSC has reported negative net income.
  • ENSC had a negative operating cash flow in the past year.
  • In the past 5 years ENSC reported 4 times negative net income.
  • ENSC had a negative operating cash flow in each of the past 5 years.
ENSC Yearly Net Income VS EBIT VS OCF VS FCFENSC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -345.10%, ENSC is doing worse than 92.10% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -911.79%, ENSC is doing worse than 79.96% of the companies in the same industry.
Industry RankSector Rank
ROA -345.1%
ROE -911.79%
ROIC N/A
ROA(3y)-319.99%
ROA(5y)-221.77%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ENSC Yearly ROA, ROE, ROICENSC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 5K 10K 15K

1.3 Margins

  • ENSC does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ENSC Yearly Profit, Operating, Gross MarginsENSC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600 -800

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. ENSC Health Analysis

2.1 Basic Checks

  • ENSC has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for ENSC has been reduced compared to 5 years ago.
  • Compared to 1 year ago, ENSC has an improved debt to assets ratio.
ENSC Yearly Shares OutstandingENSC Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
ENSC Yearly Total Debt VS Total AssetsENSC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • Based on the Altman-Z score of -69.64, we must say that ENSC is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -69.64, ENSC is doing worse than 92.87% of the companies in the same industry.
  • There is no outstanding debt for ENSC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -69.64
ROIC/WACCN/A
WACCN/A
ENSC Yearly LT Debt VS Equity VS FCFENSC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 1.27 indicates that ENSC should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.27, ENSC is doing worse than 83.43% of the companies in the same industry.
  • A Quick Ratio of 1.27 indicates that ENSC should not have too much problems paying its short term obligations.
  • ENSC's Quick ratio of 1.27 is on the low side compared to the rest of the industry. ENSC is outperformed by 82.85% of its industry peers.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 1.27
ENSC Yearly Current Assets VS Current LiabilitesENSC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. ENSC Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 79.48% over the past year.
  • Looking at the last year, ENSC shows a small growth in Revenue. The Revenue has grown by 1.51% in the last year.
  • ENSC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.86% yearly.
EPS 1Y (TTM)79.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-222.86%
Revenue 1Y (TTM)1.51%
Revenue growth 3Y13.86%
Revenue growth 5YN/A
Sales Q2Q%-85.58%

3.2 Future

  • Based on estimates for the next years, ENSC will show a very strong growth in Earnings Per Share. The EPS will grow by 40.64% on average per year.
  • The Revenue is expected to grow by 176.07% on average over the next years. This is a very strong growth
EPS Next Y64%
EPS Next 2Y40.64%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-10.84%
Revenue Next 2Y-41.42%
Revenue Next 3Y176.07%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ENSC Yearly Revenue VS EstimatesENSC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2027 20M 40M 60M 80M
ENSC Yearly EPS VS EstimatesENSC Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -1K -2K -3K

More info and screens

Find the best growth stocksShow best growing peers

1

4. ENSC Valuation Analysis

4.1 Price/Earnings Ratio

  • ENSC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year ENSC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ENSC Price Earnings VS Forward Price EarningsENSC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ENSC Per share dataENSC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ENSC's earnings are expected to grow with 40.64% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.64%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ENSC Dividend Analysis

5.1 Amount

  • No dividends for ENSC!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ENSC Fundamentals: All Metrics, Ratios and Statistics

ENSYSCE BIOSCIENCES INC

NASDAQ:ENSC (3/13/2026, 8:22:59 PM)

After market: 0.4054 0 (-0.39%)

0.407

-0.03 (-6.22%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-09
Earnings (Next)05-11
Inst Owners11.75%
Inst Owner Change42.9%
Ins Owners0.29%
Ins Owner Change0%
Market Cap1.44M
Revenue(TTM)4.49M
Net Income(TTM)-10.97M
Analysts82.86
Price Target25.73 (6221.87%)
Short Float %4.92%
Short Ratio0.02
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.92%
Min EPS beat(2)-46.21%
Max EPS beat(2)34.36%
EPS beat(4)2
Avg EPS beat(4)9.75%
Min EPS beat(4)-46.21%
Max EPS beat(4)54.8%
EPS beat(8)5
Avg EPS beat(8)24.08%
EPS beat(12)9
Avg EPS beat(12)31.22%
EPS beat(16)11
Avg EPS beat(16)-101.82%
Revenue beat(2)1
Avg Revenue beat(2)37.92%
Min Revenue beat(2)-30.95%
Max Revenue beat(2)106.79%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-3.81%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-34.76%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.11%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)100%
Revenue NY rev (1m)0%
Revenue NY rev (3m)100%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.32
P/FCF N/A
P/OCF N/A
P/B 1.2
P/tB 1.2
EV/EBITDA N/A
EPS(TTM)-6.37
EYN/A
EPS(NY)-0.3
Fwd EYN/A
FCF(TTM)-2.02
FCFYN/A
OCF(TTM)-1.99
OCFYN/A
SpS1.27
BVpS0.34
TBVpS0.34
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -345.1%
ROE -911.79%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-319.99%
ROA(5y)-221.77%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover1.41
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.27
Quick Ratio 1.27
Altman-Z -69.64
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)79.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-222.86%
EPS Next Y64%
EPS Next 2Y40.64%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.51%
Revenue growth 3Y13.86%
Revenue growth 5YN/A
Sales Q2Q%-85.58%
Revenue Next Year-10.84%
Revenue Next 2Y-41.42%
Revenue Next 3Y176.07%
Revenue Next 5YN/A
EBIT growth 1Y-74.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-209.36%
EBIT Next 3Y51.15%
EBIT Next 5YN/A
FCF growth 1Y41.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y42.63%
OCF growth 3YN/A
OCF growth 5YN/A

ENSYSCE BIOSCIENCES INC / ENSC Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ENSYSCE BIOSCIENCES INC?

ChartMill assigns a fundamental rating of 3 / 10 to ENSC.


What is the valuation status for ENSC stock?

ChartMill assigns a valuation rating of 1 / 10 to ENSYSCE BIOSCIENCES INC (ENSC). This can be considered as Overvalued.


Can you provide the profitability details for ENSYSCE BIOSCIENCES INC?

ENSYSCE BIOSCIENCES INC (ENSC) has a profitability rating of 0 / 10.


How financially healthy is ENSYSCE BIOSCIENCES INC?

The financial health rating of ENSYSCE BIOSCIENCES INC (ENSC) is 5 / 10.